(ASX: CTD) CORPORATE TRAVEL MANAGEMENT LIMITED

Reopening delivers an 81% crash, not a re-rating: no technical structure exists at this price, and this does not qualify as a BGS 20 setup

Full BGS 20 Analysis, Revised · FY26 Result (year ended 30 June 2026) · Live reopening update, 3 September 2026 · Includes Post-Shock Reversion Setup check

Live Price Of This Analysis: $3.02–3.06 (confirmed trade, ▼81.2% on the $16.07 pre-halt close) | Market Cap (est.): ~$425m

Sector: Travel Management Services | Type of Trade: Extreme Speculative / Avoid new entries at $3 or above.

Strategy: BGS 20 | Bias: Bearish / Capitulation, technical setup does not qualify

🚩 This supersedes the pre-open version of this report. CTD has now printed a confirmed live trade at ~$3.02–3.06, down ~81% from the $16.07 pre-halt close, on by far the heaviest volume bar on the entire 3-year chart (~2.8m shares on the breakdown candle) and an RSI reading of 4.88%, the most extreme oversold print on the chart’s history. This is real, traded price discovery, not an indicative auction anymore. It is also a genuinely unusual outcome: nothing in the FY26 accounts disclosed today implies an 81% loss of enterprise value on its own. Per BGS 20 discipline, a move this size demands checking for value-trap risk before treating it as opportunity, not assuming a large fall automatically equals value.

1. Company Overview

Corporate Travel Management (CTM, ASX: CTD) is a Brisbane-headquartered corporate travel management company operating across Australia/New Zealand, North America, Asia and Europe, arranging business, government, events and some leisure travel for corporate clients. Revenue comes mostly from commissions, service fees and supplier incentives on transaction value booked through the platform rather than owning the travel product itself, so the business is largely asset-light with high operating leverage once volume returns.

CTM matters to investors right now for one reason above all others: it is emerging from one of the more serious corporate accounting failures on the ASX in recent years. A KPMG UK forensic review found that CTM’s UK subsidiary had charged customers in excess of contractual entitlement across FY19 to FY25, triggering a trading halt in August 2025, a $370M prior-year goodwill impairment, a $348.5M FY25 statutory loss, and more than a year without a tradeable share price. FY26 is the first clean set of numbers since that halt, and the market is about to price it for the first time today.

What the market may be under- or over-estimating: bulls will point to underlying EBITDA up 36%, transaction volumes up 13%, $669M of new business wins and $1.5bn of re-tenders/renewals despite the scandal, nil net debt and a fresh $175M funding package. Bears will point to a qualified audit opinion on the very report that’s being used to justify reinstatement, operating cash flow down 79%, free cash flow essentially at breakeven, a further $141.7M of customer refunds due out the door in FY27, and the simple fact that nobody has traded this stock live in over a year.

2. Fundamentals

FY26 (year ended 30 June 2026) vs FY25. Figures are Reported facts unless flagged. Percentage changes are omitted, and a dollar swing shown instead, wherever the prior period was negative or near zero, per BG Trading convention.

Metric	FY26	FY25	Change
✅ Revenue & other income	$669.9m	$643.4m	+4.1%
✅ Underlying EBITDA (+margin)	$113.6m (17.0%)	$83.6m (13.0%)	+35.9%
✅ Statutory EBITDA (+margin)	$83.9m (12.5%)	$70.8m (11.0%)	+18.5%
✅ Operating profit/(loss)	$28.9m	$(361.8)m	+$390.6m swing, % not meaningful (prior period was a loss)
✅ Statutory NPAT (attributable)	$17.7m	$(348.5)m	+$366.2m swing, % not meaningful (prior period was a loss)
✅ EPS (basic)	~12.7c (BG Trading estimate, ~139m shares; not disclosed in extracted note 6)	~-$2.45 (BG Trading estimate)	Swing to positive, not meaningful as %
🚩 Operating Cash Flow	$29.6m	$141.6m	-79.1%
🚩 Free Cash Flow (OCF − capex)	$(0.6)m	$102.7m	-$103.3m swing, % not meaningful (near-zero current base)
🚩Cash balance	$106.9m	$124.0m	-13.8%
Interest-bearing debt	Nil	Nil	No change
🚩 Net cash	$106.9m	$124.0m	-13.8%
🚩 Goodwill (% of total assets)	$544.4m (43.6%)	$568.0m (43.4%)	-4.1%
New business wins (TTV)	$669m	n/a	Reported fact, FY26 only
Re-tenders & renewals (TTV)	$1.5bn	n/a	Reported fact, FY26 only
TTV / Transaction volumes	$9.8bn / 18.3m	$9.6bn / 16.2m	+2% / +13%

Revenue growth of 4% looks modest next to the 36% underlying EBITDA jump, and that gap is the single most important thing to understand about this result: most of the EBITDA improvement is the non-repeat of one-off FY25 costs (impairment, additional audit costs) rather than pure operating leverage on new volume. Genuinely encouraging is that EBITDA growth wasn’t the only positive line: transaction volumes (+13%) and TTV (+2%) both grew through a year in which the company was in a public accounting scandal, which says something about client stickiness. Working against that story is operating cash flow, down 79% to $29.6m, and free cash flow essentially at breakeven, both dragged down by $23.8m of forensic accounting and restatement costs and a $23.1m swing in payables. Revenue growth in isolation would look fine; set against a near-zero FCF year, it isn’t yet a clean recovery.

Segment Detail (FY26, Reported fact)

Segment	Revenue	Underlying EBITDA	Change (EBITDA)
✅ Australia & NZ	$181.4m (+6%)	$39.2m	+53%
✅ North America	$311.0m (-4%)	$62.3m	flat (+0.5%), FX headwind
✅ Europe	$113.7m (+34%)	$24.7m	swing from $(1.2)m loss
✅ Asia	$61.7m	$15.8m	291% change.

Summing the four segments gives underlying EBITDA of ~$142.0m against a reported group figure of $113.6m; the ~$28.4m gap is BG Trading’s inferred estimate of unallocated corporate/central costs, not a disclosed line. ANZ and Europe did the heavy lifting; North America, the largest segment by EBITDA, was essentially flat and dragged by USD weakness against AUD (-4.8% year on year per the directors’ report).

Earnings Quality

• One-off cost drag: $23.8m of forensic accounting/restatement costs and $6.0m of restructuring costs sit outside underlying EBITDA in FY26; these should fade but haven’t fully rolled off yet.
• Cash conversion: Underlying EBITDA to operating cash flow conversion was weak in FY26 ($29.6m OCF vs $113.6m underlying EBITDA); FY25 converted far more cleanly ($141.6m OCF vs $83.6m underlying EBITDA).
• Auditor opinion: Deloitte issued a Qualified Opinion on the FY26 financial report, with an Emphasis of Matter on customer related liabilities. A qualified opinion is a serious, uncommon flag from a Big Four auditor and should not be waved away as boilerplate.
• No further impairment: Unlike FY25’s $370m goodwill write-down, FY26 carried no new impairment charge.
• Revenue quality: Organic (client retention/new wins), not acquisition-driven; commissions, service fees and supplier incentives are the dominant lines, consistent with the historical mix.

Classification: LOW. The underlying EBITDA growth story is real but leans heavily on non-repeat costs rather than demonstrated operating leverage, cash conversion was weak, and a qualified audit opinion on the very report being used to justify ASX reinstatement is a genuine, not cosmetic, earnings-quality concern.

Balance Sheet

• Nil debt: Zero interest-bearing borrowings at 30 June 2026, for the second straight year.
• Cash: $106.9m (includes $15.8m client cash), down from $124.0m, plus access to a $140m syndicated facility ($75m RCF, $65m bank guarantee) and a newly announced $175m committed funding package specifically to fund remediation.
• Refund schedule vs cash generation: $141.7m of customer refunds are contractually due in FY27 and a further $30.3m in FY28, against a year in which operating cash flow was only $29.6m. The funding package and cash balance cover this on paper, but it materially reduces headroom if trading softens.
• Goodwill concentration: $544.4m of goodwill is 43.6% of total assets, all sitting in ANZ, North America and Asia CGUs following the FY25 European write-off; any further deterioration in those regions carries impairment risk.
• Refinancing language from the Directors themselves: Note 1 states the Group will “either refinance the debt facilities in 2029 or have sufficient time to agree an alternative source of finance, which may include an equity issuance” — the Board is explicitly flagging potential dilution as a live contingency, not something BG Trading is speculating into existence.

Classification: ADEQUATE. No debt is a genuine strength, but a shrinking cash balance, weak current-year cash generation, and a large near-dated remediation payment schedule mean this isn’t “strong” in the way a nil-debt balance sheet normally would be.

Fundamental Growth

• Past (FY25→FY26): Revenue +4%, underlying EBITDA +36% (low-quality, cost-driven), transaction volumes +13%.
• Current (FY27 month one): July 2026 transaction volumes +6.7% (1.6m vs 1.5m), but TTV -1.2% ($830m vs $840m) and revenue -8.6% ($53.3m vs $58.3m), which management attributes to seasonality, client mix and FX. One month is not a trend, but it’s a soft opening print right after a headline EBITDA beat.
• Future (confirmed pipeline): $178m of new business wins TTV year-to-date in FY27, plus the renewed UK MOD Afghan Resettlement Programme contract, expected to generate ~GBP28m TTV in its first six months.

Trend classification: STABLE, not yet ACCELERATING. The FY26 EBITDA growth is real but substantially a function of one-off costs not repeating, revenue growth itself is modest, and the first month of FY27 actually softened on TTV and revenue. This is a company stabilising off a low base, not one that has clearly turned the corner on organic growth yet.

Pipeline / Contract Coverage

CTM doesn’t report a formal “backlog” the way a construction or defence contractor would; the closest analogues are new business wins and re-tenders/renewals measured on a TTV basis. FY26’s $669m of new wins plus $1.5bn of re-tenders/renewals, against $9.8bn of total TTV, implies the company retained the large majority of its existing book through a period of genuine reputational stress, which is a reasonable proxy for client stickiness even without a formal coverage ratio. Never treat these figures as contracted, fixed revenue: TTV-based wins convert to actual commission/fee revenue only as clients travel, and the UK MOD contract is explicitly flagged by the company as volume-dependent, not fixed.

FY27 Projection

FY26 is already fully reported, so this projection covers FY27. Management has issued no quantitative FY27 guidance; the company has said only that trading in July 2026 was “broadly in line with expectations” and that further guidance will come at the AGM in November 2026. The scenarios below are explicitly BG Trading estimates, not company guidance or analyst consensus (none was available in the supplied materials).

Scenario	Revenue Growth	Underlying EBITDA	Key assumption
BEAR	Flat to -2%	~$120-123m	Client attrition from scandal fallout continues; July’s soft TTV/revenue print extends through the year; one-off costs fade only partially.
BASE	+4% to +6%	~$128-131m	Forensic/restatement costs largely roll off; ANZ/Europe momentum continues; NA stays roughly flat on FX; MOD contract ramps as planned.
BULL	+8% to +10%	$136m+	Reinstatement sentiment converts into new corporate mandates; MOD contract and other new wins convert faster than planned; NA FX headwind reverses.

One confirmed FY27 P&L item worth flagging explicitly: the August 2026 settlement of $195.0m of customer related liabilities for $166.6m in cash means a $28.4m gain will be recognised in the FY27 income statement as those liabilities are released, a genuine, disclosed (Note 35) tailwind to FY27 statutory NPAT that has nothing to do with underlying trading. Because only annual figures were supplied (no half-year split), an implied-2H-achievability assessment isn’t possible from the documents provided.

Forward Outlook (beyond FY27)

Management’s stated priorities beyond FY27 are: completing remediation, strengthening the balance sheet, embedding governance/control enhancements, and improving operating performance across the Group, underpinned by four strategic shifts toward a more integrated global model. No multi-year revenue or margin targets were disclosed in the supplied materials. As a BG Trading estimate, if remediation costs fully roll off and volume growth continues at a mid-single-digit pace, underlying EBITDA margin could migrate back toward the high-teens over two to three years, but this is an assumption, not guidance, and hinges on the qualified-opinion issues being fully resolved first.

Fundamental Valuation

Recalculated using the confirmed live price of ~$3.06. This is now a real, traded valuation, not a stale estimate, though it may still move intraday as the order book works through 13 months of pent-up flow.

Market Cap (138,936,922 shares × $3.06)	~$425m
Enterprise Value (Mkt Cap + Debt − Cash)	~$318m
P/E (Mkt Cap / NPAT)	~24.0x
EV / Underlying EBITDA	~2.8x
EV / Statutory EBITDA	~3.8x
EV / Revenue	~0.47x
Price / Sales	~0.63x
FCF Yield	~-0.1% (FCF was $(0.6)m in FY26; still negligible)
Cash as % of Market Cap	~25% ($106.9m cash against a $425m market cap, with nil debt)

On pure multiples this now screens as statistically very cheap: an EV/EBITDA under 3x and a quarter of the market cap covered by net cash would normally be a classic deep-value setup for a profitable, debt-free business. That’s exactly the trap the BGS 20 “Extreme Discount” band warns about. This isn’t a business whose EBITDA outlook changed today; the FY26 numbers behind this valuation were disclosed two days ago and haven’t moved. What changed is that 13 months of trapped holders got their first chance to sell, on top of whatever weight the qualified audit opinion is now carrying with the market. Classification: can’t be honestly classified as UNDERVALUED or EXPENSIVE yet — the price is cheap on the numbers and expensive on the uncertainty; BG Trading’s discipline says don’t call this “value” until the reason for an 81% single-session repricing is understood.

Peer Comparison

Metric	CTD (ref. price)	Flight Centre (FLT)	WEB Travel Group (WEB)
Business model	Managed corporate travel (agent)	Corporate + leisure travel agency	B2B hotel wholesale (WebBeds), less directly comparable
Market Cap	~$425m (post-crash)	~$2.6bn	Not confirmed in this session’s research
FY26 Revenue growth	+4%	TTV +5% to $25.7bn (revenue not itemised here)	+20% to $394.1m
FY26 EBITDA growth	+36% underlying (cost-driven)	Underlying PBT cut mid-year on Middle East disruption	Underlying EBITDA +23% to $148.4m
Debt/Cash	Nil debt, $106.9m cash	Convertible notes, active buybacks	~$500m pro forma liquidity post note redemption
Audit opinion	Qualified	Unqualified (per FY26 result release)	Unqualified (per FY26 result release)

CTD stands out from both peers for the wrong reason right now: it’s the only one of the three carrying a qualified audit opinion and the only one without a live, continuously traded price. Flight Centre is the more directly comparable business model and trades on more modest multiples given its own recent earnings disappointments; WEB Travel Group’s B2B wholesale model isn’t a clean like-for-like but shows what a clean-audit, double-digit-growth travel business looks like on both growth and cash conversion, a useful contrast to CTD’s FY26 print. Best risk/reward in this set, on the evidence available, sits with Flight Centre or WEB rather than CTD until CTD clears its audit qualification and establishes a live price.

3. Macro

Global corporate travel demand has broadly normalised post-pandemic, which is supportive background for the sector. The single most important variable for CTM specifically is FX: North America is its largest EBITDA segment and was flat in FY26 only because a 4.8% USD/AUD deterioration was offset by operational efficiency, while GBP exposure sits directly against the UK customer settlement liabilities. Episodic geopolitical shocks (the Middle East disruption that hit Flight Centre’s FY26 leisure result) are a real swing factor for both leisure and business travel.

Classification: NEUTRAL, structurally supportive demand backdrop offset by real FX and geopolitical swing risk.

Industry / Thematic

The global corporate travel management market is large (commonly cited around USD 1 trillion in transaction value) and highly fragmented, with digital-native platforms and supplier-direct channels applying continuous pricing and share pressure on traditional managed-travel providers. Consolidation is ongoing among the larger listed players. Classification: EXPANDING, but competitively intense; CTM’s growth here is being driven by client retention and re-tenders (share defence) more than new-market share gains or pricing power.

4. Catalysts

Horizon	Catalyst	Importance	Status
0-3mo	ASX trading reinstatement	Very High	Confirmed, occurring today
0-3mo	UK MOD Afghan Resettlement Programme contract ramp (~GBP28m TTV, first 6 months)	Moderate-High	Confirmed
3-6mo	Resolution of remaining ~22% of customer refund claims	Moderate	Confirmed, ongoing
3-6mo	FY27 AGM guidance	High	Confirmed, November 2026
6-12mo	Progress toward a clean (unqualified) audit opinion	High	Speculative timing
12-24mo	2029 debt facility refinancing decision (Board has flagged possible equity issuance as an alternative)	Moderate	Confirmed as a Board consideration; timing speculative

5. Risks

• Governance/audit: Qualified audit opinion on the FY26 report, with unresolved measurement uncertainty around customer related liabilities. Probability: already occurred. Impact: High.
• Technical/liquidity: Confirmed. The reopening produced an 81% single-session collapse on the heaviest volume bar on record, consistent with 13 months of trapped holders exiting at once. Probability: Occurred. Impact: High.
• Index/flow risk: A market cap collapse from ~$2.2bn to ~$425m is large enough to put CTD’s ASX 200 index membership at risk at the next rebalance; index removal would force further mechanical selling from index-tracking funds independent of fundamentals. Probability: Medium (depends on rebalance timing and any recovery). Impact: Medium-High.
• Financial: Operating cash flow -79%, free cash flow near breakeven, cash balance declining. Probability: Medium-High. Impact: Medium-High.
• Execution: $141.7m of refunds due in FY27 against modest current cash generation, partly bridged by the new $175m facility. Probability: Medium. Impact: High.
• Fundamental: Revenue growth modest, FY27 opening month softened on TTV and revenue. Probability: Medium. Impact: Medium.
• Valuation: Already rich on trailing underlying EBITDA at the stale reference price. Probability: High (of volatility around this level). Impact: High.
• Industry/Macro: FX (USD, GBP) and competitive intensity from digital-native and B2B platforms. Probability: Medium. Impact: Medium.
• Dilution: The Board itself has named a possible future equity issuance as a refinancing contingency. Probability: Low near-term. Impact: Medium-High if triggered.

Greatest risk of permanent capital loss: the combination of the qualified audit opinion and unresolved customer-liability measurement uncertainty. If further remediation claims or cost overruns emerge beyond what’s already provisioned, cash headroom could tighten quickly, given how weak FY26 operating cash flow already was, forcing a distressed refinancing or the dilutive equity issuance the Directors themselves have flagged as a live contingency.

6. Technical Analysis (delegated to the BGS 20 Technical skill, live post-reopening chart supplied)

Verdict up front: this does not qualify as a BGS 20 setup. There is no visible chart structure, prior support, or basing pattern anywhere near $3.06 anywhere on this three-year chart. Per the framework’s own rule, support and resistance must come from visible chart structure, not be invented, and a stop-loss must sit at a real technical invalidation level, not be reverse-engineered from a target. Neither exists yet at this price. What follows describes what happened and why it doesn’t clear the bar for an entry, not a trade plan.

Trend & Moving Averages (Daily, live)

• EMA9: price has gapped and crashed straight through it in a single session — Strong Bearish, short-term.
• SMA40: ≈$15.45, essentially unchanged from pre-halt since it’s a lagging average of prices that never traded; price now sits ~80% below it — this line will take many months to catch down to price and is not a near-term support.
• SMA250: ≈$13.79, similarly stale and irrelevant as a near-term reference; price is now ~77.8% below it.

SMA250 Technical Valuation Band (mandatory check)

✅ Distance from SMA250 = (3.06 − 13.785) / 13.785 × 100 ≈ -77.8%.

✅ This places CTD deep in the Extreme Discount band (more than 50% below SMA250). Per the framework, this band requires an active check for value-trap risk, structural deterioration, insolvency, persistent lower lows, heavy distribution, absence of support, before it can be treated as an opportunity rather than a warning. On the evidence in this report (qualified audit opinion, weak FY26 free cash flow, $141.7m of near-dated refund obligations, and a single un-based capitulation candle with no test of demand yet), the value-trap checklist is not cleared. This is a flag, not a bargain signal, until proven otherwise.

Price Structure

The prior three-year story (2024 decline, H2 2024 base, 2025 recovery toward $16-19) is now historical context only. Today added a single, enormous breakaway gap down through every prior level on the chart, with no basing, no retest, and no higher low yet established at these levels. Classify: Deteriorating / Capitulation, a fresh, un-based breakdown rather than a continuation of the prior “Improving” structure this report described before the open.

Support & Resistance

• Nearest support: none visible. This is the lowest print on the entire supplied chart history by a wide margin; the only reference points are the $3.00 psychological round number and today’s own intraday low, neither of which is a tested technical level.
• Nearest resistance: not meaningfully definable yet either; today’s high of the crash session (~$3.05-3.06 area) is the only near-term reference, and it’s untested.
• Former reference levels: SMA40 (~$15.45), SMA250 (~$13.79) and the old BGS20 target ($19.95) are all now so far overhead they carry no near-term relevance; keep them only as multi-month, not multi-week, reference points.

RSI

• Reading: 4.88%, the single most extreme oversold print anywhere on this chart’s three-year history (prior troughs bottomed in the 20s). Per the framework, extreme oversold readings are not automatically bullish, especially alongside a fundamental catalyst and heavy distribution volume; this can be genuine capitulation exhaustion or it can persist if forced/index selling continues over coming sessions.

Volume

• Breakdown volume: ~2.8m shares traded on the crash candle, by far the heaviest bar on the entire chart (prior spikes topped out under ~1m). Classify: Strong Distribution. This is genuine, heavily-traded price discovery, not a thin, easily-reversed gap.

Chart Pattern, Breakout & Gap Status

This is a textbook breakaway gap to the downside: a single session gapping and closing well below all prior structure on record volume. No VCP, no reversal candle, no fake-breakout characteristics apply here; this is a confirmed breakdown, not a false move. Heiken Ashi candles are in use, which can visually smooth the true scale of a move like this, so the underlying gap is likely even sharper on a standard candlestick chart than it appears here.

Entry Hierarchy, Stop-Loss & Targets

This content is only available for VIP Members.

Trade Quality & Technical Risk

Trade Quality: ★ Avoid at $3 or above. Technical Risk:

Extreme Speculative. Not because the business is necessarily worthless at $3, but because there is no chart-based way to define risk on it yet, and BGS 20 will not manufacture one.

Post-Shock Reversion Setup Check (new rule, Step 2a)

CTD is exactly the kind of situation this rule exists for, and exists to be cautious about: a capitulation event, an extreme discount, and RSI at 4.88%. All four conditions are required together for this to qualify as a genuine Post-Shock Reversion Setup rather than a value trap.

1. Confirmed one-off event, not ongoing deterioration	🚩 Fails. Deloitte issued a Qualified Opinion on the FY26 report, tied to unresolved measurement uncertainty in customer related liabilities (Note 16). By definition, a qualified audit opinion means the underlying matter is not yet fully resolved. This is precisely the “unresolved one-off” exclusion the rule names.
2. Fundamentals genuinely positive post-event, evidenced	🚩 Weak. Underlying EBITDA +36% is genuine, but operating cash flow -79% and free cash flow near breakeven in the same period undercut a clean “fundamentals are fine” read.
3. Technically discounted directly from the event	✅ Met. The ~81% gap is a direct, same-session result of the reinstatement.
4. RSI below 30	✅ Met. RSI at 4.88%, the most extreme reading on the chart’s history.

Result: does not qualify as a Post-Shock Reversion Setup. Two of the four required conditions fail. Per the rule, a partial pass doesn’t count, missing condition 1 (an unresolved issue behind the “one-off” event) is specifically called out as the value-trap signature the rule is built to catch, regardless of how attractive the price or how oversold the RSI looks. This falls back to the standard verdict below.

Probability View

These are technical/fundamental judgment calls based on the combined evidence, not statistical forecasts. Given there is no defined support yet, this is deliberately wide.

Continues lower / stays under heavy selling as trapped holders and any forced index sellers keep exiting over coming sessions~40%

Stabilises and bases somewhere in the low-to-mid $3s over the next few sessions~35%

Sharp reflexive bounce as the extreme RSI reading and statistically cheap multiples attract opportunistic buyers~25%

7. Entry, Targets & Risk Management (This area is only Open for Paid Subscribers.

Investor Suitability

Classification: AGGRESSIVE / SPECULATIVE / TRADERS ONLY. This is not currently suitable for CONSERVATIVE or passive LONG-TERM allocation: a qualified audit opinion, weak free cash flow, a large near-dated remediation cash outflow, and a same-day reinstatement with no live trading history over the past year are all genuine, stated reasons for caution, not boilerplate risk language. Opportunity type: SPECULATIVE POSITION, potentially a short-term trading opportunity around reopening volatility for experienced traders comfortable with binary-event risk, not a medium- or long-term investment case until the audit qualification clears and a real price forms.

BGS 20 Score (revised for live price)

Fundamentals50 × 15% = 7.50

Growth45 × 10% = 4.50

Balance Sheet55 × 10% = 5.50

Valuation55 × 20% = 11.00

Technical15 × 10% = 1.50

Catalysts55 × 10% = 5.50

Industry/Macro55 × 10% = 5.50

Risk/Reward25 × 15% = 3.75

Weighted sum ÷ 1.00 (all categories assessed)45 / 100

Score band: 45, still below – 50 HIGH RISK / AVOID. Valuation actually moved up (statistically cheap multiples now), but Technical and Risk/Reward both collapsed because there is no defined chart structure and no honest way to size risk on this stock yet. The net score barely changed, 47 to 45, which is itself the point: an 81% price collapse without new information doesn’t make this a materially better or worse business, it makes it a much harder one to size a position in responsibly. CTD was also explicitly checked against the new Post-Shock Reversion Setup exception (Section 15) and does not qualify, the qualified audit opinion behind the crash disqualifies it on condition 1 alone, so no upward adjustment for that exception was applied here.

20. Bull / Base / Bear Cases & Fair Value

Method: EV/EBITDA applied to BG Trading’s FY27 underlying EBITDA scenarios (Section 7), against net cash and 138.9m shares. All figures are BG Trading estimates.

Case	FY27E Underlying EBITDA	Target EV/EBITDA	Implied Price	vs $16.07
Bear	~$120m	10x	~$9.29	-42.2%
Base	~$129m	13x	~$12.87	-19.9%
Bull	~$138m	16x	~$16.83	+4.7%

Current Price vs Base Fair Value % = (12.87 − 3.06) / 3.06 × 100 ≈ +321%. The live price is now dramatically below every one of these fundamentals-based scenarios, including the bear case. Two honest readings are possible, and BG Trading can’t yet tell you which is right: either the market is pricing in something worse than what’s in the FY26 accounts (further undisclosed liabilities, insolvency risk, a much harsher view of the qualified audit than this report has taken), or this is a liquidity-driven overshoot from 13 months of trapped selling that will partially mean-revert once the order book clears. The size of the gap between $3.06 and even the bear case ($9.29) is itself informative: markets don’t normally move this far past a bear case without either new information or forced, non-fundamental selling. Don’t resolve that uncertainty with the fundamentals model alone; wait for the technical section (Section 15) to actually clear before acting on it.

An 81% crash on unchanged fundamentals is a red flag to investigate, not a discount to buy.

CTD’s FY26 numbers didn’t get worse between yesterday and today, underlying EBITDA up 36%, nil debt and $106.9m cash are exactly what they were when this report was first drafted this morning. What changed is that the market got its first chance in 13 months to actually trade the stock, and it used that chance to take 81% off the price on the heaviest volume in three years. That combination, statistically cheap multiples (sub-3x EV/EBITDA) sitting next to a genuinely extreme, un-based, high-volume breakdown, is precisely the pattern BGS 20’s Extreme Discount rule exists to slow you down on. CTD was explicitly tested against the Post-Shock Reversion Setup exception, the rule built for exactly this kind of one-off-event crash, and failed it: the “one-off event” behind the crash still carries a qualified audit opinion, i.e. unresolved uncertainty, which is the rule’s specific disqualifying case. The revised score of 45 stayed in the same below-50 band as before the open; valuation improved, but technical and risk/reward both collapsed because there is no chart structure left to size a trade against.

This is not being called AVOID because the business is bad, FY26 says otherwise, it’s AVOID because there is currently no responsible way to define risk on it. Watchlist status resumes once a genuine base forms: a low that holds on a retest, tightening ranges, and volume shifting from distribution to accumulation. Until then this is a stock to observe, not trade.

Would BG Trading buy at the live price (~$3.06)?

No. Not because it’s necessarily overvalued, and it’s not confirmed undervalued either, the multiples look statistically cheap, but Section 9 already flagged that as unresolved uncertainty rather than a genuine discount. The answer is no because there is no technical structure to define a stop against, which means no honest way to size risk, independent of which way the valuation question eventually breaks.

If not, at what price or condition?

Not a price, a condition: wait for a tested low that holds on a retest, with volume shifting from distribution to accumulation. That could be materially above or below $3.06.

Biggest reason to own it eventually?

A profitable, debt-free, cash-generative-adjacent business now trading at roughly a quarter of its pre-halt market cap, with underlying operations that didn’t deteriorate today. We wouldn’t hesitate to buy if CTD falls to low $2’s.

Biggest reason not to touch it right now?

The size and speed of the move (81% in one session) suggests either information the market has that this report doesn’t, or forced/panic selling severe enough that price is not currently a reliable signal either way.

What would confirm this is a genuine opportunity rather than a value trap?

A base forming over several sessions, volume shifting to accumulation, progress toward resolving the qualified audit opinion, and the November AGM guidance not walking back the FY26 recovery story.

What would confirm it’s a value trap?

Continued heavy distribution volume with no basing, ASX 200 index removal triggering further forced selling, or news emerging that explains the 81% move as something worse than a liquidity unwind.

Single most important thing to watch next?

Whether today’s low holds over the next several sessions, or whether the stock keeps making new lows on continued heavy volume.

Driven primarily by fundamentals, technicals, valuation, catalysts, or a combination?

Right now, almost entirely by flow and forced selling, not by anything fundamental. The fundamentals and the price have become disconnected, and this report can’t tell you which one is wrong.

Asymmetric risk/reward?

Potentially very large if a base forms, but genuinely undefined today. Undefined risk is not the same as good risk/reward.

Technically discounted, fundamentally undervalued, both, or neither?

Statistically fundamentally cheap on the numbers, but technically this is a fresh, un-based breakdown, not a “discount” in the BGS 20 sense of a level worth buying against.

Trade or long-term investment?

Neither, today. Once a base forms, this could become either, depending on how far a recovery leg runs and how the audit qualification resolves.

Disclaimer. The information contained in this report is provided by BG Trading Australia (ACN 161943228, License 4901880) for general informational purposes only and does not constitute personal financial product advice. It has been prepared without taking into account your objectives, financial situation, needs, or risk tolerance, and should not be relied upon as a substitute for independent professional advice tailored to your circumstances. Nothing in this report constitutes an offer, solicitation, or recommendation to buy, sell, or hold any financial product.

All technical levels, targets, and commentary reflect a point-in-time interpretation of publicly available chart data and are inherently speculative; markets are volatile and unpredictable, and no methodology, including the BGS 20 framework, can guarantee any particular outcome. Past performance is not, and should not be treated as, an indicator of future performance. To the maximum extent permitted by law, BG Trading Australia, its directors, employees, and agents disclaim all liability, whether direct or indirect, for any loss or damage arising from reliance on this report, including any errors, omissions, or inaccuracies in the information provided, and any decision made or action taken on the basis of it. You acknowledge that trading and investing carry inherent risk, including the risk of loss of capital, and that you act on this information entirely at your own discretion and risk. BG Trading recommends you obtain independent, licensed financial and taxation advice before making any investment decision.